WHO ICTRP trial
[A Study of Utility and Safety of 30% N2O Inhalation Sedation Applied with Nasal…
JPRN-jRCTs072240042 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs072240042 |
|---|---|
| Public title | [A Study of Utility and Safety of 30% N2O Inhalation Sedation Applied with Nasal High Flow] |
| Scientific title | A Study of Utility and Safety of 30% N2O Inhalation Sedation Applied with Nasal High Flow ~Single-center, randomized, open-label, group-comparative study~. |
| Primary sponsor | Magata Nobuaki |
| Secondary sponsors | Fisher & Paykel Healthcare Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Patients eligible for N2O inhalation sedation |
| Interventions | N2O inhalation using NHF |
| Registration date | Jul 29, 2024 |
| Target size | 60 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: